We are live on ! Find out more
FWM

Fairhaven Wealth Management Portfolio holdings

AUM $320M
1-Year Est. Return 17.7%
This Fund
S&P 500
This Quarter Est. Return
-5.62%
1 Year Est. Return
+17.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$246M
AUM Growth
-$9.95M
Cap. Flow
+$8.11M
Cap. Flow %
3.29%
Top 10 Hldgs %
57.56%
Holding
136
New
15
Increased
60
Reduced
14
Closed
8

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.56M
2
ADM icon
Archer Daniels Midland
ADM
+$1.46M
3
TGT icon
Target
TGT
+$1.38M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.38M
5
ENB icon
Enbridge
ENB
+$1.33M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$1.6M
2
DIS icon
Walt Disney
DIS
+$1.49M
3
NVS icon
Novartis
NVS
+$1.33M
4
RBLX icon
Roblox
RBLX
+$1.07M
5
UL icon
Unilever
UL
+$359K

Sector Composition

Rank Sector Weight
1 Technology 9.86%
2 Healthcare 7.71%
3 Consumer Discretionary 7.68%
4 Financials 7.14%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
126
Ardelyx
ARDX
$1.23B
$21K 0.01%
20,000
+10,000
+100% +$8.93K
DKNG icon
127
CALL
DraftKings
DKNG
$11.6B
$2K ﹤0.01%
+10,000
New +$212K
ABBV icon
128
AbbVie
ABBV
$436B
-1,877
Closed -$254K
CDW icon
129
CDW
CDW
$18.9B
-1,083
Closed -$222K
MQT
130
DELISTED
BlackRock MuniYield Quality Fund II
MQT
-13,314
Closed -$197K
QUAL icon
131
iShares MSCI USA Quality Factor ETF
QUAL
$47B
-1,421
Closed -$207K
TSM icon
132
TSMC
TSM
$2.11T
-1,671
Closed -$201K
UL icon
133
Unilever
UL
$137B
-5,937
Closed -$359K
WST icon
134
West Pharmaceutical
WST
$24.5B
-431
Closed -$202K
XLK icon
135
State Street Technology Select Sector SPDR ETF
XLK
$117B
-2,392
Closed -$208K

Similar funds

Fairhaven Wealth Management's Q1 2022 Portfolio in Review

As of Q1 2022, Fairhaven Wealth Management held 136 positions worth $246M, down 3.9% from $256M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Fairhaven Wealth Management deployed $8.11M of net new capital in Q1 2022, opening 15 new positions and adding to 60 existing holdings. Its largest new stake was Merck: 19,753 shares worth $1.62M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.6M trimmed.

  • Fairhaven Wealth Management's largest Q1 2022 buy was Merck: 19,753 shares worth $1.62M.
  • Fairhaven Wealth Management added most to iShares Core S&P 500 ETF in Q1 2022, an estimated $1.38M increase.
  • Fairhaven Wealth Management's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.6M.
  • Fairhaven Wealth Management fully exited Unilever in Q1 2022, selling an estimated $359K.
  • Fairhaven Wealth Management's ten largest holdings make up 58% of its $246M portfolio in Q1 2022.
  • Fairhaven Wealth Management opened 15 new positions and closed 8 in Q1 2022.
  • Fairhaven Wealth Management's portfolio value fell 3.9% quarter-over-quarter to $246M.

Based on Fairhaven Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.